A Phase 2 Randomized, Controlled, Double-Masked Trial to Evaluate the Safety and Efficacy of Intravitreal 4D-150 Gene Therapy in Adults with Diabetic Macular Edema (SPECTRA Study)
Research Grant
Administered By
Ophthalmology
Awarded By
4D Molecular Therapeutics
Start Date
March 1, 2023
End Date
November 30, 2027
Administered By
Ophthalmology
Awarded By
4D Molecular Therapeutics
Start Date
March 1, 2023
End Date
November 30, 2027